Skip to McMaster Navigation Skip to Site Navigation Skip to main content

AstraZeneca moves to acquire McMaster-supported Fusion Pharmaceuticals for $2.4 billion (US)

John Valliant speaks at a podium in front of a Fusion banner

Posted on May 29, 2024

Read more at Brighter World.

Entrepreneurship

From left to right: Provost Susan Tighe, Celesta founding and managing partner Sriram Viswanathan, President David Farrar, Celesta CEO Nicholas Brathwaite, Associate Vice-president of Research Leyla Soleymani and acting Vice-President of Research Andy Knights.

Brighter World ➚

McMaster and Celesta partner to accelerate deep tech innovation and commercialization

Entrepreneurship

May 29, 2024

Brighter World ➚

McMaster awarded $300,000 from Intellectual Property Ontario to boost innovation and commercialization

Entrepreneurship

May 29, 2024